SITE MAP   |   CONTACT US

Investor Relations




The Investor Relations section provides the latest Biovail news, product and financial information, including quarterly results, webcasts, and more. It is regularly updated with the latest Biovail information.

   More
13.74 14.79
up-0.22
-1.6%
up-0.11
-0.74%
As of: 08/02/10 08/02/10
 
9908.39 11898.69
up-103.84
+-1.05%
up51.72
+0.43%
As of: 08/02/10 08/02/10

Stock Chart
Note: The stock price performance shown on the quote above is not necessarily indicative of the future price performance

Copyright © 1998-2002 MarketWatch.com Inc. User agreement applies. Historical and current end-of-day data provided by Interactive Data Corp. Intraday data is at least 20-minutes delayed. All times are EDT. Intraday data provided by S&P Comstock and subject to terms of use.



01/22/2010 3:02 PM
Biovail Comments on Proposed Generic Wellbutrin XL(R) Trial

01/06/2010 11:33 AM
Biovail to Present at JPMorgan Healthcare Conference

11/10/2009 1:58 PM
Biovail to Participate at Upcoming Conferences

11/05/2009 7:03 AM
Biovail Reports Third-Quarter 2009 Financial Results

11/05/2009 7:00 AM
Biovail Declares Quarterly Dividend

        Go to News Archive


For additional information on Investor Relations, please contact:

Nelson F. Isabel, CFA
Vice-President, Investor Relations and Corporate Communications 
Phone: 905.286.3000
Fax: 905.286.3050
Email: ir@biovail.com





Registrars and Transfer Agents

CIBC Mellon Trust Company
Toronto, ON Canada

ChaseMellon Shareholder Services L.L.D.
New York, NY U.S.A.

Independent Accountants

Ernst & Young LLP


Tools

Investment Calculator


Email Alerts

Resources

Q3/2009 Financial Results

Biovail's Product Pipeline 

Pimavanserin Schizophrenia Co-Therapy - Phase 2 Data 

Aplenzin Prescribing Information

Nitoman Prescribing Information 

Xenazine Prescribing Information

Xenazine Medication Guide

Corporate Fact Sheet

IMPORTANT:  Income Tax Information for Canadian Resident Shareholders

 

 
 

Download Adobe Acrobat Reader

Events




© 2007 Biovail Corporation - All Rights Reserved (BIO113B0602) Privacy Policy   |   Disclaimers